Mikhail Blagosklonny is an eminent scientist and oncologist known for his groundbreaking research in the field of pathological oncology. Currently, Mikhail Blagosklonny is serving as a professor of oncology in New York at the Rosewell Park Cancer Institute.
Blagosklanny studied internal medicine and did his doctorate in experimental medicine and cardiology from the First Pavlov State Medical University of St. Petersburg. After that, in 2002 he got a position of assistant professor of medicine at New York Medical College. Blagosklanny then moved on to Ordway Research Institute, Albany as a higher-ranking scientist and worked there until 2009. Since then he has been serving as a professor at Rosewell Park Cancer Institute. Visit classroomvoices.org to read more about Mikhail.
His research focus has been on translating basic sciences into new anticancer strategies like exploiting cancer cell cycle and introducing drug resistance for selective protection of cancer cells. He has extended his research to other age-related diseases and aging by coming up with anti-aging drugs. Blagosklonny also authored hyper-function theory of aging and also prevalent anti-cancer approaches such as chemotherapy and psychotherapy which are widely used around the world to cure cancer. Millions of cancer patients continue to live undergoing these procedures brought about by Blagosklonny. Mikhail Blagosklonny received enormous academic accreditation for his groundbreaking theoretical construct regarding the probable role of TOR technique in aging and cancer and came up with the proposition to use an anti-cancer drug called rapamycin for curing cancer and extending life.
Blagosklonny edits the internationally acclaimed journal Oncotarget which he co-founded in 2010. He also edits several other research journals that focus on cancer aging and other related diseases. Investing a huge amount of efforts in research, he has published scores of research articles on the subject. In short, the life of Mikhail Blagosklonny is dedicated to saving lives through his exemplary acumen for research in the fields of oncology and aging. His year’s long research culminated into innovative techniques to get the human lives rid of the dangerous disease of cancer. Read more on Hardware Gurus.